Transient fluctuations of intracellular zinc ions in cell proliferation

Experimental Cell Research

Volumn 315, Issue 14, 2009, Pages 2463-2470

  Li, Yuan ^a   Maret, Wolfgang ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cell cycle; Differentiation; Pheochromocytoma (PC12) cells; Proliferation; Zinc

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FLUORESCENT DYE; NERVE GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE; ZINC ION;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CELL VIABILITY; CHELATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 67649229609     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.05.016     Document Type: Article

References (45)

1. Vallee B.L., and Falchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 73 (1993) 79-118
2. Beyersmann D., and Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 14 (2001) 331-341
3. 2+ requirement for DNA synthesis by 3T3 cells. Exp. Cell Res. 184 (1989) 499-508
4. 2+ for the induction of thymidine kinase but not ornithine decarboxylase in 3T3 cells stimulated from quiescence. Biochem. J. 272 (1990) 525-527
5. 2+ requirement for DNA synthesis by 3T3 cells. Exp. Cell Res. 192 (1991) 631-634
6. Watanabe K., Hasegawa K., Ohtake H., Tohyama C., and Koga M. Inhibition of DNA synthesis by EDTA and its cancellation by zinc in primary cultures of adult rat hepatocytes. Biomed. Res. 14 (1993) 99-110
7. Chesters J.K., and Petrie L. A possible role for cyclins in the zinc requirements during G1 and G2 phases of the cell cycle. J. Nutr. Biochem. 10 (1999) 279-290
8. Cho Y., Gorina S., Jeffrey P.D., and Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 (1994) 346-355
9. Sim K.G., Zang Z., Yang C.M., Bonventre J.V., and Hsu S.I. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability. Cell Cycle 3 (2004) 1296-1304
10. Sun L., Chai Y., Hannigan R., Bhogaraju V.K., and Machaca K. Zinc regulates the ability of Cdc25C to activate MPF/cdk1. J. Cell Physiol. 213 (2007) 98-104
11. Ducruet A.P., Vogt A., Wipf P., and Lazo J.S. Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 725-750
12. Wong S.H., Shih R.S., Schoene N.W., and Lei K.Y. Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells. Am. J. Physiol., Cell Physiol. 294 (2008) C1342-C1349
13. Haase H., and Maret W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp. Cell Res. 291 (2003) 289-298
14. Krezel A., and Maret W. Thionein/metallothionein control Zn(II) availability and the activity of enzymes. J. Biol. Inorg. Chem. 13 (2008) 401-409
15. Krezel A., and Maret W. Zinc-buffering capacity of a eukaryotic cell at physiological pZn. J. Biol. Inorg. Chem. 11 (2006) 1049-1062
16. Bozym R.A., Thompson R.B., Stoddard A.K., and Fierke C.A. Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor. ACS Chem. Biol. 1 (2006) 103-111
17. Paski S.C., and Xu Z. Labile intracellular zinc is associated with 3T3 cell growth. J. Nutr. Biochem. 12 (2001) 655-661
18. Paski S.C., and Xu Z. Growth factor stimulated cell proliferation is accompanied by an elevated labile intracellular pool of zinc in 3T3 cells. Can. J. Physiol. Pharmacol. 80 (2002) 790-795
19. Simpson M., and Xu Z. Increased abundance of labile intracellular zinc during cell proliferation was due to increased retention of extracellular zinc in 3T3 cells. J. Nutr. Biochem. 17 (2006) 541-547
20. Yamasaki S., Sakata-Sogawa K., Hasegawa A., Suzuki T., Kabu K., Sato E., Kurosaki T., Yamashita S., Tokunaga M., Nishida K., and Hirano T. Zinc is a novel intracellular second messenger. J. Cell Biol. 177 (2007) 637-645
21. Martina C., Martineza R., Navarroa R., Ruiz-Sanza J.I., Lacorta M., and Ruiz-Larrea M.B. tert-Butyl hydroperoxide-induced lipid signaling in hepatocytes: involvement of glutathione and free radicals. Biochem. Pharmacol. 62 (2001) 705-712
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol. Meth. 65 (1983) 55-63
23. Pardee A.B. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 71 (1974) 1286-1290
24. Schmidt C., and Beyersmann D. Transient peaks in zinc and metallothionein levels during differentiation of 3T3L1 cells. Arch. Biochem. Biophys. 364 (1999) 91-98
25. Apostolova M.D., and Cherian M.G. Delay of M-phase onset by aphidicolin can retain the nuclear localization of zinc and metallothionein in 3T3-L1 fibroblasts. J. Cell Physiol. 183 (2000) 247-253
26. van Grunsven L.A., Thomas A., Urdiales J.L., Machenaud S., Choler P., Durand I., and Rudkin B.B. Nerve growth factor-induced accumulation of PC12 cells expressing cyclin D1: evidence for a G1 phase block. Oncogene 12 (1996) 855-862
27. Rudolf E. Increased uptake of zinc in malignant cells is associated with enhanced activation of MAPK signaling and P53-dependent cell injury. Acta Medica (Hradec. Kralove) 51 (2008) 43-49
28. Klein C., Creach K., Irintcheva V., Hughes K.J., Blackwell P.L., Corbett J.A., and Baldassare J.J. Zinc induces ERK-dependent cell death through a specific Ras isoform. Apoptosis 11 (2006) 1933-1944
29. Rudkin B.B., Lazarovici P., Levi B.Z., Abe Y., Fujita K., and Guroff G. Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation. EMBO J. 8 (1989) 3319-3325
30. Urdiales J.L., Becker E., Andrieu M., Thomas A., Jullien J., van Grunsven L.A., Menut S., Evan G.I., Martin-Zanca D., and Rudkin B.B. Cell cycle phase-specific surface expression of nerve growth factor receptors TrkA and p75(NTR). J. Neurosci. 18 (1998) 6767-6775
31. Traverse S., Gomez N., Paterson H., Marshall C., and Cohen P. Sustained activation of the mitogen-activated (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem. J. 288 (1992) 351-355
32. Grummt F., Weinmann-Dorsch C., Schneider-Schaulies J., and Lux A. Zinc as a second messenger of mitogenic induction. Effects on diadenosine tetraphosphate (Ap4A) and DNA synthesis. Exp. Cell Res. 163 (1986) 191-200
33. Rudolf E., and Cervinka M. External zinc stimulates proliferation of tumor Hep-2 cells by active modulation of key signaling pathways. J. Trace Elem. Med. Biol. 22 (2008) 149-161
34. Balaji R.V., and Colvin R.A. A proton-dependent zinc uptake in PC12 cells. Neurochem. Res. 30 (2005) 171-176
35. Segal D., Ohana E., Besser L., Hershfinkel M., Moran A., and Sekler I. A role for ZnT-1 in regulating cellular cation influx. Biochem. Biophys. Res. Commun. 323 (2004) 1145-1150
36. Hogstrand C., Kille P., Nicholson R.I., and Taylor K.M. Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol. Med. 15 (2009) 101-111
37. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Signal. 8 (2006) 1419-1441
38. Maret W. Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 237-241
39. Li Y., and Maret W. Human metallothionein metallomics. J. Anal. At. Spectrom. 23 (2008) 1055-1062
40. Tsujikawa K., Suzuki N., Sagawa K., Itoh M., Sugiyama T., Kohama Y., Otaki N., Kimura M., and Mimura T. Induction and subcellular localization of metallothionein in regenerating rat liver. Eur. J. Cell Biol. 63 (1994) 240-246
41. Andrews G.K., Gallant K.R., and Cherian M.G. Regulation of the ontogeny of rat liver metallothionein mRNA by zinc. Eur. J. Biochem. 166 (1987) 527-531
42. Cai L., Wang G.J., Xu Z.L., Deng D.X., Chakrabarti S., and Cherian M.G. Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. Anticancer Res. 18 (1998) 4667-4672
43. Nagel W.W., and Vallee B.L. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 579-583
44. Studer R., Vogt C.P., Cavigelli M., Hunziker P.E., and Kägi J.H. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochem. J. 328 (1997) 63-67
45. Lim D., Jocelyn K.M., Yip G.W., and Bay B.H. Silencing the metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells. Cancer Lett. 276 (2009) 109-117